课题基金 / 基金详情

PHASE II STUDY OF RECOMBINANT BETA AND GAMMA INTERFERON IN LUNG CANCER

PHASE II STUDY OF RECOMBINANT BETA AND GAMMA INTERFERON IN LUNG CANCER
重组 β 和 γ 干扰素治疗肺癌的 II 期研究
批准号：
3904524
负责人：
RONALD BLUM
金额：
$0.0万
依托单位：
NEW YORK UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/3904524
关键词：
combination cancer therapy human subject human therapy evaluation immunological substance interferons lung neoplasms metastasis monocyte neoplasm /cancer chemotherapy neoplasm /cancer immunotherapy tumor necrosis factor alpha

项目摘要

项目成果

RONALD BLUM的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This study will to determine the toxicity of combined recombinant interferon gamma and beta serine in patients with metastic non-small cell carcinoma of the lung; the response rate of this therapy as measured by disease-free survival and overall survival; the immune-modifying activity of this combined therapy as measured by induction of TNF; the expression of Class II HLA antigen on monocytes and the correlation of this to survival; the immune-modifying activity of this combined therapy as measured by induction of TNF; the expression of Class II HLA antigen on monocytes and the correlation of this to clinical response.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ECOG C9344 DOXORUBICIN DOSE ESCALATION +/- TAXOL FOR NODE POSITIVE BREAST CANCER
SWOG 94-20 CORRELATION OF THYMIDYLATE SYNTHASE IN 5 FU TREATED COLORECTAL CANCER
ECOG S9313--ADJUVANT CHEMOTHERAPY IN HIGH RISK BREAST CANCER PATIENTS
ECOG 91140--CDP, DTIC, CARMUSTINE & TAMOXIFEN VS DTIC IN ADVANCED MELANOMA
海外基金